Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development

Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development / Powles, T; Necchi, A; Rosen, G; Hariharan, S; Apolo, Ab. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1558-7673. - 16:2(2018), pp. 117-129. [10.1016/j.clgc.2017.11.002]